| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 9 | |
| #2 | Canada | 4 | |
| #3 | United States | 4 | |
| #4 | EPO (European Patent Office) | 3 | |
| #5 | Australia | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Machines | |
| #5 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Unspecified technologies | |
| #7 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Wu James M | 5 |
| #2 | Feldman Richard I | 5 |
| #3 | Monahan John J | 5 |
| #4 | Brunck Terence K | 5 |
| #5 | Bluford Peter | 4 |
| #6 | Hancock Miriam E C | 4 |
| #7 | Chao Lorrine A | 4 |
| #8 | Stuart Susan G | 3 |
| #9 | Slattery Timothy K | 3 |
| #10 | Harkins Richard N | 3 |
| Publication | Filing date | Title |
|---|---|---|
| EP0497866A1 | Gastrin releasing peptide receptor | |
| WO9013652A1 | Herpes simplex virus type 2-glycoprotein g proteins and polypeptides | |
| US4999421A | HTLV-I anti-sense RNA and encoded proteins | |
| US5003043A | Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof | |
| US4772684A | Peptides affecting blood pressure regulation | |
| EP0294390A1 | Peptides affecting blood pressure regulation |